Editorial comment on: neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
Wyndaele
Jean-Jacques
JJ
Department of Urology, University Antwerp and University Hospital Antwerp, Edegem, Belgium. Jean-Jacques.Wyndaele@ua.ac.be
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D003558:Cystoscopy; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D013118:Spinal Cord Diseases / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014563:Urodynamics
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A